cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.fwa76k
title: Occurrence Download

description: A dataset containing 456 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Apostichopus japonicus (Selenka, 1867)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 456 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057626-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.yvx5nq
title: Occurrence Download

description: A dataset containing 414 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Coastal and Marine Species Database"
 ]
}

 The dataset includes 414 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057627-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jk87wt
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Stichopus japonicus Selenka, 1867",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 4 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057628-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8dupb2
title: Occurrence Download

description: A dataset listing the 176 species recorded in GBIF matching the query:
{
 "DatasetKey" : [
 "is Coastal and Marine Species Database"
 ]
}

 The dataset's 176 records were derived from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057622-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.6shstd
title: Occurrence Download

description: A dataset containing 261 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Doederleinia berycoides (Hilgendorf, 1879)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 261 records from 18 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057629-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.47p8sp
title: Occurrence Download

description: A dataset containing 19001 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Orcinus orca (Linnaeus, 1758)",
 "Year 2000-2025"
 ]
}

 The dataset includes 19001 records from 217 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057630-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ye6sgy
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Anthias berycoides Hilgendorf, 1879",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057631-241126133413365/datasets/export for details.
DOI: 10.5281/zenodo.14603103
title: Global Genetic Engineering Market 2024 To 2033

description: Genetic Engineering Market Size, Trends and Insights By Product (Biochemical, Genetic Markers), By Devices (PCR, Gene Gun, Gel Assemblies), By Techniques (Gene Splicing, Artificial Selection, Recombinant DNA Technology, Synthesizing DNA, Gene Editing, Other), By Application (Agriculture, Medical Industrial), By End-User (Biotechnology Companies, Pharmaceutical Manufacturers, Academic and Research Institutions, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

Global Genetic Engineering Market was valued at USD 1,491.6 Million in 2024 and is expected to reach USD 2,917.2 Million by 2033, at a CAGR of 6.74% during the forecast period 2024 – 2033.

Genetic engineering is the process of directly manipulating an organism’s genes. Scientists can insert new genes, remove unwanted ones, or change existing ones. This allows for the creation of organisms with desired traits, like pest-resistant crops or bacteria that produce medicine.

The genetic engineering market focuses on the tools and techniques used in this manipulation. This includes things like enzymes for cutting DNA, genetic material like plasmids, and even software for designing genetic modifications. The market is expected to grow significantly in the coming years, driven by factors like increasing demand for personalized medicine and advancements in gene editing techniques like CRISPR.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50137
DOI: 10.5281/zenodo.14603104
title: Global Genetic Engineering Market 2024 To 2033

description: Genetic Engineering Market Size, Trends and Insights By Product (Biochemical, Genetic Markers), By Devices (PCR, Gene Gun, Gel Assemblies), By Techniques (Gene Splicing, Artificial Selection, Recombinant DNA Technology, Synthesizing DNA, Gene Editing, Other), By Application (Agriculture, Medical Industrial), By End-User (Biotechnology Companies, Pharmaceutical Manufacturers, Academic and Research Institutions, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

Global Genetic Engineering Market was valued at USD 1,491.6 Million in 2024 and is expected to reach USD 2,917.2 Million by 2033, at a CAGR of 6.74% during the forecast period 2024 – 2033.

Genetic engineering is the process of directly manipulating an organism’s genes. Scientists can insert new genes, remove unwanted ones, or change existing ones. This allows for the creation of organisms with desired traits, like pest-resistant crops or bacteria that produce medicine.

The genetic engineering market focuses on the tools and techniques used in this manipulation. This includes things like enzymes for cutting DNA, genetic material like plasmids, and even software for designing genetic modifications. The market is expected to grow significantly in the coming years, driven by factors like increasing demand for personalized medicine and advancements in gene editing techniques like CRISPR.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50137
DOI: 10.15468/dl.vbb29z
title: Occurrence Download

description: A dataset containing 428 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sebastes inermis Cuvier, 1829",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 428 records from 23 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057632-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.z7p6jt
title: Occurrence Download

description: A dataset containing 44 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Minous quincarinatus (Fowler, 1943)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 44 records from 13 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057633-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.thnnjd
title: Occurrence Download

description: A dataset containing 414 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Coastal and Marine Species Database"
 ]
}

 The dataset includes 414 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057634-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ekpr7z
title: Occurrence Download

description: A dataset containing 145 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Fistularia petimba Lacepède, 1803",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 145 records from 27 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057635-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14603113
title: India Tissue Engineering Market 2024 To 2033

description: India Tissue Engineering Market Size, Trends and Insights By Product (Synthetic Scaffold Material, Biologically Derived Scaffold Material, Others), By Application (Orthopedics and Musculoskeletal, Neurology, Cardiovascular, Skin and Integumentary, Dental, Others), By Product Type (Scaffold, By Material, Tissue Grafts, By Type, Other Products), By End User (Hospitals, Specialty Centers and Clinics, Ambulatory Surgical Centers) and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Tissue Engineering Market was valued at USD 352.6 Million in 2024 and is expected to reach USD 598.2 Million by 2033, at a CAGR of 11.1% during the forecast period 2024 – 2033.

Tissue engineering is an interdisciplinary field combining principles of engineering, biology, and medicine to create functional biological substitutes for damaged or diseased tissues. This involves the design and fabrication of scaffolds, often using biomaterials, which mimic the extracellular matrix of native tissues.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50427
DOI: 10.5281/zenodo.14603114
title: India Tissue Engineering Market 2024 To 2033

description: India Tissue Engineering Market Size, Trends and Insights By Product (Synthetic Scaffold Material, Biologically Derived Scaffold Material, Others), By Application (Orthopedics and Musculoskeletal, Neurology, Cardiovascular, Skin and Integumentary, Dental, Others), By Product Type (Scaffold, By Material, Tissue Grafts, By Type, Other Products), By End User (Hospitals, Specialty Centers and Clinics, Ambulatory Surgical Centers) and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Tissue Engineering Market was valued at USD 352.6 Million in 2024 and is expected to reach USD 598.2 Million by 2033, at a CAGR of 11.1% during the forecast period 2024 – 2033.

Tissue engineering is an interdisciplinary field combining principles of engineering, biology, and medicine to create functional biological substitutes for damaged or diseased tissues. This involves the design and fabrication of scaffolds, often using biomaterials, which mimic the extracellular matrix of native tissues.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50427
DOI: 10.15468/dl.7yjsc4
title: Occurrence Download

description: A dataset containing 140 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Acetes japonicus Kishinouye, 1905",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 140 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057636-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9bbebd
title: Occurrence Download

description: A dataset containing 1658 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruditapes philippinarum (A.Adams & Reeve, 1850)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 1658 records from 42 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057638-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.g834hs
title: Occurrence Download

description: A dataset containing 11854 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Bulweria bulwerii (Jardine & Selby, 1828)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 11854 records from 12 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057639-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14603127
title: India Artificial Organs and Bionics Market 2024 To 2033

description: India Artificial Organs and Bionics Market Size, Trends and Insights By Type (Artificial Organs, Artificial Bionics), By Technology (Mechanical Bionics, Electronic Bionics), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Artificial Organs and Bionics Market was valued at USD 590.6 Million in 2024 and is expected to reach USD 898.2 Million by 2033, at a CAGR of 9.3% during the forecast period 2024 – 2033.

Artificial organs and bionics are both fields of medical technology aimed at replacing or enhancing the function of organs or body parts. Bionics combines biology and electronics to create devices that can interact with the human body to restore or augment its capabilities.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50421
DOI: 10.5281/zenodo.14603128
title: India Artificial Organs and Bionics Market 2024 To 2033

description: India Artificial Organs and Bionics Market Size, Trends and Insights By Type (Artificial Organs, Artificial Bionics), By Technology (Mechanical Bionics, Electronic Bionics), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Artificial Organs and Bionics Market was valued at USD 590.6 Million in 2024 and is expected to reach USD 898.2 Million by 2033, at a CAGR of 9.3% during the forecast period 2024 – 2033.

Artificial organs and bionics are both fields of medical technology aimed at replacing or enhancing the function of organs or body parts. Bionics combines biology and electronics to create devices that can interact with the human body to restore or augment its capabilities.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50421
DOI: 10.15468/dl.2n6qjx
title: Occurrence Download

description: A dataset containing 106 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Nepal",
 "TaxonKey is Hyaena hyaena (Linnaeus, 1758)"
 ]
}

 The dataset includes 106 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057640-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.pzhpjk
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Procellaria bulwerii Jardine & Selby, 1828",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057641-241126133413365/datasets/export for details.
DOI: 10.6084/m9.figshare.28140227
title: Supplementary Material for: The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates

description: Abstract:
Introduction: Lung transplantation (LT) is a lifesaving procedure in patients with end stage lung failure. The prevalence of coronary artery disease (CAD) in patients with lung disease is comparably high, and coronary angiography is widely used for coronary anatomy assessment prior to LT. Detection of significant CAD usually results in revascularization to minimize post-transplant cardiovascular events. We aim to examine the prognostic significance of CAD interventions on LT candidates pre- and post-LT. 
Methods: From a retrospective registry of 450 LT candidates undergoing cardiac catheterization during 2014-2019, patients were assessed for the presence of significant CAD and percutaneous coronary intervention. The primary outcome was defined as occurrence of major advance cardiac events (MACE) in LT candidates while on the waiting list. MACE comprising of cardiovascular mortality, non-fatal myocardial infarction (MI), target-vessel revascularization, and coronary artery bypass graft surgery (CABG)]. Secondary outcomes were the occurrence of MACE post-transplant according to the coronary intervention status. 
Results: MACE was recorded in 22 LT candidates, with a higher incidence in the intervention group compared to the non-intervention group (8.3% vs 4.4%, p=0.007). 28.6% of MACE events in the intervention group occurred in the first month after intervention. Cardiovascular mortality accounted for 8.6% of all deaths, without significant difference between the intervention and non-intervention group (16.0% vs 7.2%, p=0.155). The rates of MACE post-LT were mildly and non-significantly increased in the intervention group compared to the non-intervention group (11.1% vs 4.5%, p=0.18). 
Conclusion: Pre-LT routine coronary intervention does not necessarily protect patients from experiencing MACE while on the waiting list or post-LT.
DOI: 10.6084/m9.figshare.28140227.v1
title: Supplementary Material for: The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates

description: Abstract:
Introduction: Lung transplantation (LT) is a lifesaving procedure in patients with end stage lung failure. The prevalence of coronary artery disease (CAD) in patients with lung disease is comparably high, and coronary angiography is widely used for coronary anatomy assessment prior to LT. Detection of significant CAD usually results in revascularization to minimize post-transplant cardiovascular events. We aim to examine the prognostic significance of CAD interventions on LT candidates pre- and post-LT. 
Methods: From a retrospective registry of 450 LT candidates undergoing cardiac catheterization during 2014-2019, patients were assessed for the presence of significant CAD and percutaneous coronary intervention. The primary outcome was defined as occurrence of major advance cardiac events (MACE) in LT candidates while on the waiting list. MACE comprising of cardiovascular mortality, non-fatal myocardial infarction (MI), target-vessel revascularization, and coronary artery bypass graft surgery (CABG)]. Secondary outcomes were the occurrence of MACE post-transplant according to the coronary intervention status. 
Results: MACE was recorded in 22 LT candidates, with a higher incidence in the intervention group compared to the non-intervention group (8.3% vs 4.4%, p=0.007). 28.6% of MACE events in the intervention group occurred in the first month after intervention. Cardiovascular mortality accounted for 8.6% of all deaths, without significant difference between the intervention and non-intervention group (16.0% vs 7.2%, p=0.155). The rates of MACE post-LT were mildly and non-significantly increased in the intervention group compared to the non-intervention group (11.1% vs 4.5%, p=0.18). 
Conclusion: Pre-LT routine coronary intervention does not necessarily protect patients from experiencing MACE while on the waiting list or post-LT.
DOI: 10.15468/dl.4fuzxe
title: Occurrence Download

description: A dataset containing 110 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Atheresthes evermanni Jordan & Starks, 1904",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 110 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057642-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.msqf56
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Reinhardtius evermanni (Jordan & Starks, 1904)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057643-241126133413365/datasets/export for details.
DOI: 10.5281/zenodo.14603137
title: India Plasma Fractionation Market 2024 To 2033

description: India Plasma Fractionation Market Size, Trends and Insights By Product (Albumin, Immunoglobulin, Coagulation Factors, Others), By Application (Immunology & Neurology, Haematology, Critical Care, Pulmonology, Others), By Method (Centrifugation, Depth Filtration, Chromatography, Others), By End Use (Hospitals & Clinics, Clinical Research, Others) and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Plasma Fractionation Market was valued at USD 352.6 Million in 2024 and is expected to reach USD 498.2 Million by 2033, at a CAGR of 4.1% during the forecast period 2024 – 2033.

Plasma fractionation is a process that separates and purifies various proteins from blood plasma to produce therapeutic products. This technique involves fractionating plasma into its component proteins, such as albumin, immunoglobulins, clotting factors, and others.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50346
DOI: 10.5281/zenodo.14603138
title: India Plasma Fractionation Market 2024 To 2033

description: India Plasma Fractionation Market Size, Trends and Insights By Product (Albumin, Immunoglobulin, Coagulation Factors, Others), By Application (Immunology & Neurology, Haematology, Critical Care, Pulmonology, Others), By Method (Centrifugation, Depth Filtration, Chromatography, Others), By End Use (Hospitals & Clinics, Clinical Research, Others) and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Plasma Fractionation Market was valued at USD 352.6 Million in 2024 and is expected to reach USD 498.2 Million by 2033, at a CAGR of 4.1% during the forecast period 2024 – 2033.

Plasma fractionation is a process that separates and purifies various proteins from blood plasma to produce therapeutic products. This technique involves fractionating plasma into its component proteins, such as albumin, immunoglobulins, clotting factors, and others.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50346